Murnane KS
Department of Pharmacology, Toxicology & Neuroscience, School of Graduate Studies, Louisiana State University Health Shreveport, Shreveport, Louisiana 71103, United States.
ArticlePsilocybin
Differential Effects of Acute and Chronic Fluoxetine on Psychedelic-Induced Behavior in Mice: Implications for Clinical Trials.
ArticlePsilocybin
Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice-Lessons Learned from a State Underrepresented in Clinical Psychedelic Research.
ArticlePsilocybin
Practical considerations in the establishment of psychedelic research programs.
ArticlePsilocybin
Amid magic and menace: psychiatrists' attitudes to psilocybin therapy.
ArticleKetamine
Psychedelic Commercialization: A Wide-Spanning Overview of the Emerging Psychedelic Industry.
ArticlePsilocybin
Exploring psilocybin-assisted psychotherapy in the treatment of methamphetamine use disorder.
ArticleKetamine
Historical Pathways for Opioid Addiction, Withdrawal with Traditional and Alternative Treatment Options with Ketamine, Cannabinoids, and Noribogaine: A Narrative Review.
ArticlePsilocybin
Alternative Options for Complex, Recurrent Pain States Using Cannabinoids, Psilocybin, and Ketamine: A Narrative Review of Clinical Evidence.
ArticlePsychedelics
Effects of the synthetic psychedelic 2,5-dimethoxy-4-iodoamphetamine (DOI) on ethanol consumption and place conditioning in male mice.
ArticlePsychedelics
The adrenergic receptor antagonist carvedilol interacts with serotonin 2A receptors both in vitro and in vivo.
ArticleMDMA
Serotonin 2A receptors are a stress response system: implications for post-traumatic stress disorder.
ArticlePsychedelics
The serotonin 5-HT<sub>2C</sub> receptor and the non-addictive nature of classic hallucinogens.
ArticlePsychedelics